![](/img/cover-not-exists.png)
AB0705 EULAR sjOgren's syndrome disease activity index (ESSDAI) is sensitive to show treatment efficacy of rituximab in patients with primary sjOgren's syndrome
Moerman, R. V., Arends, S., Meiners, P. M., Meijer, J. M., Kroese, F. G., Vissink, A., Bootsma, H.Volume:
71
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.705
Date:
June, 2012
File:
PDF, 58 KB
2012